| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Fu-Pang Chang, Ting-Rong Hsu, Sheng-Che Hung, Shih-Hsien Sung, Wen-Chung Yu, Dau-Ming Niu, Behzad Najafia. Cardiomyocyte Globotriaosylceramide Accumulation in Adult Male Patients with Fabry Disease and IVS4 + 919G>A GLA Mutation is Progressive with Age and Correlates with Left Ventricular Hypertrophy and Reduced Left Ventricular Ejection Fraction. medRxiv : the preprint server for health sciences. 2024-01-03. PMID:38168318. |
cardiomyocyte globotriaosylceramide accumulation in adult male patients with fabry disease and ivs4 + 919g>a gla mutation is progressive with age and correlates with left ventricular hypertrophy and reduced left ventricular ejection fraction. |
2024-01-03 |
2024-01-06 |
Not clear |
| Fu-Pang Chang, Ting-Rong Hsu, Sheng-Che Hung, Shih-Hsien Sung, Wen-Chung Yu, Dau-Ming Niu, Behzad Najafia. Cardiomyocyte Globotriaosylceramide Accumulation in Adult Male Patients with Fabry Disease and IVS4 + 919G>A GLA Mutation is Progressive with Age and Correlates with Left Ventricular Hypertrophy and Reduced Left Ventricular Ejection Fraction. medRxiv : the preprint server for health sciences. 2024-01-03. PMID:38168318. |
while cardiovascular complications are the most common cause of mortality in fabry disease, the relationship between globotriaosylceramide (gl-3) accumulation, the hallmark of fabry cardiomyopathy, and cardiac hypertrophy has not been fully elucidated. |
2024-01-03 |
2024-01-06 |
Not clear |
| Isabel Mattig, Tilman Steudel, Gina Barzen, David Frumkin, Sebastian Spethmann, Elena Romero Dorta, Karl Stangl, Bettina Heidecker, Ulf Landmesser, Fabian Knebel, Sima Canaan-Kühl, Katrin Hahn, Anna Bran. Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease. International journal of cardiology. 2023-12-04. PMID:38048880. |
diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and fabry disease. |
2023-12-04 |
2023-12-10 |
Not clear |
| Kamil Stankowski, Stefano Figliozzi, Vincenzo Battaglia, Federica Catapano, Marco Francone, Lorenzo Mont. Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy. Journal of clinical medicine. vol 12. issue 22. 2023-11-25. PMID:38002674. |
fabry disease: more than a phenocopy of hypertrophic cardiomyopathy. |
2023-11-25 |
2023-11-28 |
Not clear |
| Maomao Zhao, Xiaowei Niu, Lu Bai, Yinchang Zhang, Ting Wang, Yongling Wa, Junchu Wei, Kang Dong, Xin Zhang, Ming Ba. Unexplained Left Ventricular Hypertrophy Diagnosed as a Cardiac Variant of Late-Onset Fabry Disease: A Case Report. Journal of cardiovascular development and disease. vol 10. issue 9. 2023-09-27. PMID:37754818. |
unexplained left ventricular hypertrophy diagnosed as a cardiac variant of late-onset fabry disease: a case report. |
2023-09-27 |
2023-10-07 |
Not clear |
| Andrea Frustaci, Valentino Borghetti, Samuele Pentiricci, Romina Verardo, Rossella Scialla, Matteo Antonio Russ. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy. ESC heart failure. 2023-09-16. PMID:37715354. |
hypertrophic obstructive cardiomyopathy caused by fabry disease: implications for surgical myectomy. |
2023-09-16 |
2023-10-07 |
Not clear |
| Andrea Frustaci, Valentino Borghetti, Samuele Pentiricci, Romina Verardo, Rossella Scialla, Matteo Antonio Russ. Hypertrophic obstructive cardiomyopathy caused by Fabry disease: implications for surgical myectomy. ESC heart failure. 2023-09-16. PMID:37715354. |
hypertrophic obstructive cardiomyopathy can be the phenotype of storage disorders as fabry disease cardiomyopathy. |
2023-09-16 |
2023-10-07 |
Not clear |
| Alice Moroni, Lara Tondi, Valentina Milani, Maurizio Pieroni, Federico Pieruzzi, Francesca Bevilacqua, Giulia Pasqualin, Kelvin Chow, Silvia Pica, Massimo Lombardi, Antonia Camporeal. Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis. International journal of cardiology. 2023-09-11. PMID:37696360. |
left atrial remodeling in hypertrophic cardiomyopathy and fabry disease: a cmr-based head-to-head comparison and outcome analysis. |
2023-09-11 |
2023-10-07 |
Not clear |
| Alice Moroni, Lara Tondi, Valentina Milani, Maurizio Pieroni, Federico Pieruzzi, Francesca Bevilacqua, Giulia Pasqualin, Kelvin Chow, Silvia Pica, Massimo Lombardi, Antonia Camporeal. Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis. International journal of cardiology. 2023-09-11. PMID:37696360. |
hypertrophic cardiomyopathy (hcm) and fabry disease cardiomyopathy (fd) are phenocopies, as they show left ventricular hypertrophy (lvh). |
2023-09-11 |
2023-10-07 |
Not clear |
| Anna Burban, Szymon Pucyło, Aleksandra Sikora, Grzegorz Opolski, Marcin Grabowski, Agnieszka Kołodzińsk. Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement. International journal of molecular sciences. vol 24. issue 17. 2023-09-09. PMID:37686045. |
this article focuses on hcm and other cardiomyopathies with myocardial hypertrophy, including fabry disease, pompe disease, and danon disease. |
2023-09-09 |
2023-10-07 |
Not clear |
| Tomás Francisco Cianciulli, María Cristina Saccheri, Mariano Napoli Llobera, Lorena Romina Balletti, Matín Alejandro Beck, Luis Alberto Morita, Jorge Alberto La. Prevalence of papillary muscle hypertrophy in fabry disease. BMC cardiovascular disorders. vol 23. issue 1. 2023-08-27. PMID:37635225. |
prevalence of papillary muscle hypertrophy in fabry disease. |
2023-08-27 |
2023-09-07 |
Not clear |
| N Aladağ, H Ali Barman, A Şipal, T Akbulut, M Özdemir, S Ceylane. Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism? Balkan journal of medical genetics : BJMG. vol 26. issue 1. 2023-08-14. PMID:37576794. |
difficulties in diagnosing fabry disease in patients with unexplained left ventricular hypertrophy (lvh): is the novel gla gene mutation a pathogenic mutation or polymorphism? |
2023-08-14 |
2023-08-16 |
Not clear |
| Jing Yong Ng, Essa Zarook, Luke Nicholson, Mohammed Yunus Khanji, Choudhary Anwar Ahmed Chaha. Eyes and the heart: what a clinician should know. Heart (British Cardiac Society). 2023-07-28. PMID:37507215. |
rarer diseases, such as fabry disease, would be accompanied by ocular signs such as cornea verticillata and such cardiac manifestations include cardiac hypertrophy as well as arrhythmias. |
2023-07-28 |
2023-08-14 |
Not clear |
| Josef Marek, Barbora Chocholová, Daniel Rob, Tomáš Paleček, Martin Mašek, Gabriela Dostálová, Aleš Linhar. Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis. European heart journal. Cardiovascular Imaging. 2023-06-13. PMID:37309820. |
fabry disease (fd) is a multisystemic lysosomal storage disorder caused by a defect in the alpha-galactosidase a gene that manifests as a phenocopy of hypertrophic cardiomyopathy. |
2023-06-13 |
2023-08-14 |
Not clear |
| Kazufumi Nakamura, Hiroshi Morita, Yoichi Takaya, Yukihiro Saito, Toru Miyoshi, Hiroshi Morinaga, Hitoshi Sugiyama, Jun Wada, Hiroshi It. Effects of Agalsidase Alfa Enzyme Replacement Therapy on Left Ventricular Hypertrophy on Electrocardiogram in a Female Patient with Fabry Disease. International heart journal. 2023-05-17. PMID:37197914. |
effects of agalsidase alfa enzyme replacement therapy on left ventricular hypertrophy on electrocardiogram in a female patient with fabry disease. |
2023-05-17 |
2023-08-14 |
Not clear |
| Giovanni Donato Aquaro, Carmelo De Gori, Lorenzo Faggioni, Maria Luisa Parisella, Dania Cioni, Riccardo Lencioni, Emanuele Ner. Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies. European heart journal supplements : journal of the European Society of Cardiology. vol 25. issue Suppl C. 2023-05-01. PMID:37125322. |
in chronic myocardial infarction, hypertrophic cardiomyopathies (hcm), dilated cardiomyopathy, fabry disease, and other conditions, lge is a marker of myocardial fibrosis, but also in patients with acute myocarditis where lge may be also explained by the increase of interstitial space caused by interstitial oedema or by tissue infiltration of inflammatory cells. |
2023-05-01 |
2023-08-14 |
Not clear |
| Rosa Lillo, Francesca Graziani, Francesco Franceschi, Giulia Iannaccone, Massimo Massetti, Iacopo Olivotto, Filippo Crea, Giovanna Liuzz. Inflammation across the spectrum of hypertrophic cardiac phenotypes. Heart failure reviews. 2023-04-28. PMID:37115472. |
this "umbrella diagnosis" includes the "classic" hypertrophic cardiomyopathy (hcm), due to sarcomere protein gene mutations, and its phenocopies caused by intra- or extracellular deposits, such as fabry disease (fd) and cardiac amyloidosis (ca). |
2023-04-28 |
2023-08-14 |
Not clear |
| Roxana Hiestand, Albina Nowak, Justyna M Sokolska, Raymond Chan, Frank Ruschitzka, Robert Manka, Christiane Grune. Clinical and CMR characteristics associated with cardiac events in patients with Fabry disease. International journal of cardiology. 2023-04-12. PMID:37044180. |
the assessment of late gadolinium enhancement (lge) and left ventricular hypertrophy (lvh) by cardiac magnetic resonance (cmr) as diagnostic and prognostic maker in fabry disease is advancing. |
2023-04-12 |
2023-08-14 |
Not clear |
| Maxim Avanesov, Anahid Asgari, Nicole Muschol, Anja Friederike Köhn, Enver Tahir, Gerhard Adam, Paulus Kirchhof, Gunnar Lund, Ersin Cavus, Monica Patte. Comparison of classical Fabry and its p.D313Y and p.A143T variants by cardiac T1 mapping, LGE and feature tracking myocardial strain. Scientific reports. vol 13. issue 1. 2023-04-10. PMID:37037838. |
cardiac manifestation of classical fabry disease (cfd) varies with sex and presence of left ventricular hypertrophy. |
2023-04-10 |
2023-08-14 |
Not clear |
| Ebru Özpelit, Yüksel Çavuşoğlu, Hikmet Yorgun, Emir Özgür Barış Ökçün, Rabia Eker Akıllı, Ahmet Çelik, Necip Ermiş, Demet Menekşe Gerede Uludağ, Gokhan Kahveci, Şefika Uslu Çil, Erkan Erfidan, Omaç Tufekciogl. The Frequency of Fabry Disease in Patients with Cardiac Hypertrophy of Various Phenotypes Including Prominent Papillary Muscle: The TUCARFAB Study in Turkey. Anatolian journal of cardiology. vol 27. issue 4. 2023-03-30. PMID:36995061. |
the frequency of fabry disease in patients with cardiac hypertrophy of various phenotypes including prominent papillary muscle: the tucarfab study in turkey. |
2023-03-30 |
2023-08-14 |
Not clear |